// App-Quantinova.ai

: Association between ICS therapy for COPD and diabetes onset and progression

Researchers

Presenter

  • Jaco Voorham

Principal Investigators

  • Nicolas Roche

  • Jeffrey Stephens

  • Hye Yun Park

  • Robert Fogel

  • Andreas Clemens

  • Guy Brusselle

  • David Price

Medical Centers

  • Observational and Pragmatic Research Institute, Singapore, Singapore,

  • University Paris Descartes (EA2511), Cochin Hospital Group (AP-HP), Paris, France

  • ABMU / Swansea University, Swansea, United Kingdom.

  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of,

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

  • Novartis AG, Basel, Switzerland

  • Ghent University Hospital, Ghent, Belgium

Locations

  • Singapore

  • France

  • United Kingdom

  • Republic of South Korea

  • United States

  • Switzerland

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Type 2 diabetes mellitus

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved